ILMN Key Stats
- 6 Ways You Can Profit From Molecular Diagnostics May 22
- Roche, Sigma teamed up for failed Life Technologies bid: sources May 21
- Roche, Sigma teamed up for failed Life Technologies bid -sources May 21
- QIAGEN Downgraded to Strong Sell - Analyst Blog Zacks May 21
- Opportunities in Hepatitis C and Genomic Technologies: a Wall Street Transcript ... May 21
- Splicing & Dicing Myriad Genetics Amidst the Angelina Jolie Disclosure May 21
- QIAGEN Downgraded to Strong Sell May 21
- The 3 Deadliest Diseases in the U.S. May 20
- Illumina Inc. Presents at UBS Global Healthcare Conference, May-20-2013 11:30 AM Seeking Alpha May 20
- Illumina Inc. (ILMN): Today's Featured Health Care Winner May 20
ILMN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Illumina is up 61.87% over the last year vs S&P 500 Total Return up 27.81%, Life Technologies up 76.50%, and Alkermes up 106.1%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for ILMN
Pro Report PDF for ILMN
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download ILMN Pro Report PDF
Pro Strategies Featuring ILMN
Did Illumina make it into our Pro Portfolio Strategies?